Loading patent…
AssigneeAbdula KURKAYEV
InventorABDULA KURKAYEV
Estimating the term…
The method of obtaining stable suspensions of heterocrystals of titanium dioxide and particles of silicon dioxide representing special class of quantum dots (QD). and stable suspensions obtained in such a way for initiation of active form of oxygen in the human body in use in medical forms. Starting material: Initial stuff in the form of aggregates with size more than 0.5 micrometer is mixed with an aqueous solution of pharmaceutical inorganic acid, with subsequent direction to homogenizing for the first stage of mixing, after that the obtained aqueous suspension is subjected to thermal treatment and, then aqueous suspension is directed to the rotary rotor-type evaporator periodically for evaporation of inorganic acid with suspension expense trough the rotor-type evaporator no more than 25 l/min and then the obtained activated particles are mixed with water in hydrodynamical cavitation-wave cavitational homogenizer to quasi-with regulated pulsating wave mode until obtaining stable suspension of heterocrystal of titanium dioxide or particles of silicon dioxide with size less than 450 nm, and presence on the lattice surface up to 60-80% of electronically-excited triplet oxygen 3+TO23O2 in the energy centers, namely, in the quantum dots—zones of local overheating, ensuring heat synthesis catalytic activity for formation of active forms of oxygen in the living organism human body. The surface of Stable suspension obtained by said method is characterized by distribution of activated crystals of titanium dioxide or with size up to 1 nm being 0.3 vol %, up to 20 nm being 5-40 vol %, particles with size up to 80 nm being 10-80 vol %, particles with size up to 150 nm being 5-30 vol %, particles with size up to 250 nm being 5-20 vol %, particles with size more than 250 nm-no more than 10 vol %, and distribution of activated particles of silicon dioxide with size 40-80 nm being 10-80 vol %, particles with size 80-150 nm being 10-80 vol %, particles with size 150-250 nm being less than 30 vol %, particles with size more than 250 nm—no more than 15%. The surface of heterocrystals of titanium dioxide and particles of silicon dioxide has sorption ability, that is an important factor for use in medical forms, ensuring detoxication of an organism, elimination of hypoxia, antiviral effect of a medical agent, antipathogenous effect in the body of living organism and elimination of under oxidation processes in the human body, increasing induction of immune response of vertebrata.
The method of obtaining stable suspensions of heterocrystals of titanium dioxide or particles of silicon dioxide characterized by the fact that the starting material is in the form of aggregates with size more than 0.5 micrometer is mixed with an aqueous solution of pharmaceutically acceptable acid, with subsequent direction to homogenizing for the first stage of mixing, after that the obtained aqueous suspension is subjected to thermal treatment, then aqueous suspension is directed to the rotary rotor-type evaporator working under pressure lower than 100 kPa at temperature no more than 70° C. 70° C. for evaporation of pharmaceutically acceptable inorganic acid with suspension expense trough the rotor-type evaporator no more than 25 l/min and then the obtained activated particles are mixed with water in hydrodynamical cavitational homogenizer with regulated pulsating wave mode until obtaining stable suspension of heterocrystals of titanium dioxide or particles of silicon dioxide with size less than 450 nm, and presence on the lattice surface 60% up to 80% of electronically-excited triplet oxygen 3+TO23O2 in the energy centers, namely, in the quantum dots—zones of local overheating, ensuring catalytic activity for formation of active forms of oxygen in the human body of a living organism.
Dependencies are inferred from the claim text.